DCOY · ISSUER CIK 1615219
Decoy Therapeutics Inc.
Between Aug 1, 2026 and Oct 29, 2026, 10 Decoy Therapeutics Inc. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗10 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Sep 2, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 2, 202618:32 | Aug 31, 2026 | DCOY | Director | A · Grant | — | +2,000 | 2,002 | +100000% | — | ||
| Sep 2, 202617:50 | Aug 31, 2026 | DCOY | Chief Executive Officer | A · Grant | — | +33,455 | 34,844 | +2409% | — | ||
| Sep 2, 202617:49 | Aug 31, 2026 | DCOY | Chief Business Officer | A · Grant | — | +3,900 | 3,900 | New | — | ||
| Sep 2, 202617:48 | Aug 31, 2026 | DCOY | Chief Financial Officer | A · Grant | — | +9,682 | 11,363 | +576% | — | ||
| Sep 2, 202617:46 | Aug 31, 2026 | DCOY | Chief Scientific Officer | A · Grant | — | +4,216 | 4,216 | New | — | ||
| Sep 2, 202617:45 | Aug 31, 2026 | DCOY | Director | A · Grant | — | +3,000 | 3,418 | +718% | — | ||
| Sep 2, 202617:42 | Aug 31, 2026 | DCOY | Director | A · Grant | — | +2,000 | 2,001 | +200000% | — | ||
| Sep 2, 202617:41 | Aug 31, 2026 | DCOY | Director | A · Grant | — | +2,000 | 2,002 | +100000% | — | ||
| Sep 2, 202617:40 | Aug 31, 2026 | DCOY | Director | A · Grant | — | +3,000 | 3,002 | +150000% | — | ||
| Sep 2, 202617:39 | Aug 31, 2026 | DCOY | Director | A · Grant | — | +2,000 | 2,000 | New | — |